Search for: "Pharmaceutical Staff" Results 1 - 20 of 1,298
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Jun 2024, 3:33 am by Rob Robinson
Industry News – Antitrust Beat Novartis Faces Critical Legal Challenges in Drug Pricing and Antitrust Cases ComplexDiscovery Staff The pharmaceutical giant Novartis is currently embroiled in several legal disputes that underscore the contentious issues facing the industry, particularly around drug pricing and antitrust regulations. [read post]
3 Jun 2024, 12:03 pm by Barbara Moreno
Comprised of original articles, court decisions, and legislation on topics including medical ethics, clinical criminology, pharmaceutical law, and more. [read post]
24 May 2024, 3:00 am by Jim Sedor
National/Federal With Debate Deal, Trump and Biden Sideline a Storied Campaign Institution DNyuz – Adam Nagourney (New York Times) | Published: 5/16/2024 The agreement by President Biden and Donald Trump to move ahead with two presidential debates, and sideline the Commission on Presidential Debates, is a debilitating and potentially fatal blow to an institution that had once been a major arbiter in presidential politics. [read post]
19 May 2024, 9:05 pm by The Regulatory Review
Sep 21, 2023 | HHS Selects Drugs for Medicare Price Negotiation | Biden Administration introduces price regulation to the pharmaceutical industry. [read post]
22 Apr 2024, 5:00 am by Bernard Bell
The first, the Sixth Circuit’s “authority or duty” test, required plaintiffs to prove “state action” by establishing that either (1) the “text of state law requires an officeholder to maintain a social-media account,” (2) the defendant official “use[s] … state resources” or “government staff” to run the account, or (3) the “accoun[t] belong[s] to an office, rather than an individual officeholder. [read post]
19 Apr 2024, 5:13 am by David M. Boertje
Professionals and staff who try to cheat health insurance companies are a serious concern because there are multiple ways to engage in a swindle, and a successful fraudster can essentially steal big dollars and impact patient outcomes. [read post]
10 Apr 2024, 9:00 am by ricelawmd_3p2zve
This ensures that the staff are competent and capable of providing quality care to patients. [read post]
8 Apr 2024, 3:15 am by Kurt R. Karst
Unfortunately, it is also unencumbered by any explanation about what those expedited reviews looked like, or, for example, how OPQ coordinates with CDER’s Drug Shortage Staff. [read post]
30 Mar 2024, 6:52 am by Lebowitz & Mzhen
Every patient deserves peace of mind when it comes to their medications, and to live free of the consequences of medical and pharmaceutical malpractice. [read post]
22 Mar 2024, 1:27 pm by John Ross
" Regeneron Pharmaceuticals sues Novartis over antitrust claims related to prescription medications used to treat the overproduction of vascular endothelial growth factor (VEGF). [read post]
6 Mar 2024, 12:34 pm by Ginger Buck
” This cross-agency initiative reinforces the government’s priority in scrutinizing PE firms and other entities that acquire or invest in healthcare companies and analyzing the impact such transactions may have on patients, staff, and taxpayers. [read post]
1 Mar 2024, 12:39 pm by luiza
  It is the second-largest set of criminal financial penalties ever levied against a pharmaceutical company. [read post]
14 Feb 2024, 3:48 am by Rob Robinson
Her words reflect the USPTO’s determination to honor human contribution even amidst the burgeoning capabilities of generative AI across myriad industries, from pharmaceuticals’ accelerated drug development to the precision-crafted materials science breakthroughs. [read post]
13 Feb 2024, 1:33 am by Kluwer Patent blogger
‘It is a great effort to onboard and train new people, both judges and staff. [read post]
10 Feb 2024, 6:02 pm by Yosi Yahoudai
He now works in marketing for Thompson Tractor Company in Birmingham, Alabama, and has an eye toward medical equipment or pharmaceutical sales as another possible career option. [read post]
25 Jan 2024, 5:31 am by Ashley Morgan
Health Care Provider Risks When Ordering and Billing Chelation Therapy Services (January 25, 2024): Although chelation therapy[1] has played an important role in mainstream medicine for many years,[2] it is still considered by many clinicians and regulators to fall within the category of "Complementary and Alternative Medicine. [read post]
24 Jan 2024, 9:01 pm by renholding
Would a pharmaceutical company that takes more than 12 or 18 months to bring a drug to market suddenly find itself primarily engaged in the business of investing in securities? [read post]
12 Jan 2024, 9:40 am by luiza
” RDx and its owner/CEO “allegedly paid specimen collection fees to the staff members of referring healthcare providers to induce those providers to order RDx laboratory testing. [read post]